Bioeconomy in China: An Overview and Perspective - Yin Li - Global Bioeconomy Summit 2018
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Bioeconomy in China:
An Overview and Perspective
Yin Li
Institute of Microbiology, Chinese Academy of Sciences
yli@im.ac.cn
Evolution of the Chinese bioindustry and its policy support
Marked the beginning In 2006, development of
of the modern bioindustry became one of the top
bioindustry in China priorities for the Chinese economy
Current status of the bioindustry
The total output value of China' s Chinese bioindustry is mainly
bioindustry in 2015-2030 classified into seven major fields:
Trillion annual growth rate of 22.9% Biomedicine
RMB (56.9 trillion GDP in 2013, 3.5%)
16 16
14 Biomedical engineering
12
10
8
8 Bio-agriculture
6 4
4
2 Bio-based manufacturing
0
2015 2020 2030
The total output value of China's Bioenergy
bioindustry was expected to hit:
RMB 4 trillion (US$ 630 billion) by the Bio-based environmental protection
end of 2015
RMB 8 trillion by the end of 2020
Biotechnology service
RMB 16 trillion by the end of 2030
Subdivision of the bioindustry and
the expected annual output value by the end of 2015*
Output value
Fields Subdivisions
(RMB billion)
Biotechnology medicine
Biomedicine Chemical medicine 2,100
Traditional Chinese medicine
High-performance biomedical instruments
Biomedical
Biomedical materials 400
engineering
Novel diagnostic products
Bio-breeding
Bio-agriculture Agro-bioproducts 300
Marine bioresources
Bio-based products including bio-based materials
Bio-based
Bio-based chemicals and bulk fermentation products 750
manufacturing
Green bioprocesses
Biomass electricity
Bioenergy Biogas & biofuel 150
Biomass pellet
Bio-based environmental protection 150
Biotechnology services 150
Total 4,000
Patents in Chinese biotechnology from 2006 to 2015 In 10 years since 2006: the number of biotechnology patents has continuously increased the applied for and approved patents reached 22,193 (25.46% of global ones) and 10,394 (21.28%) both ranked the second in the world China's share of patents in the global biotechnology field also increased continuously
China's innovation capacity in the fields of life sciences and
biotechnology is continuously increasing
In 2015, publications from China reached 87,765, second only to USA
The rank of publications from China in the world
the 2th in the world
Till now
From 2013 to 2015, the output value maintained an average annual growth rate of over 20%
the 2th in the world
2011 In 2010, the biological industry was listed as a strategic emerging industry, which marked the
beginning of its rapid development
the 4th in the world
2010
In 2010, Decision of the State Council on Accelerating the Fostering and Development of Strategic
Emerging Industries was formally issued the 8th in the world
2006 In 2006, The State Council issued the National Medium and Long-term
Program for Science and Technology Development (2006-2020), in which
biotechnology was one of the important development directions
Biomedicine
Gross output value of national medical and
pharmaceutical industry from 2007 to 2014 From 2007 to 2014, the
gross output value of
30000 medical and
Gross industrial output value
25798
25000 22297 pharmaceutical
(RMB 00,000,000)
18770
20000
15624
industry stably grew in
15000 12350 China
9947
10000 8382
6719
5000 Reached RMB 2,688.52
0
billion in 2015,
2007 2008 2009 2010 2011 2012 2013 2014 increased by 9.0%,
Year
higher than the
Data source: (1) South Medicine Research Institute, 2014, national industrial
Blue Book on the Development of China's Medical and growth rate 8.2%
Pharmaceutical Market in 2014; (2) Health Wealth Forum on
China's Medical and Pharmaceutical Industrial Chain in 2015.
Biomedical engineering
The sales of medical devices in China have continuously increased and reached
RMB 308 billion in 2015, almost 6 times the amount (RMB 53.5 billion) in 2007
High-performance Biomedical Novel diagnostic
1biomedical instruments 2 materials 3 products
The sales of medical China's the market sales China has now become
devices in China have amount in 2020 will be globally the largest
continuously increased US$ 120 billion, become emerging market for in
and reached RMB 308 the second biggest vitro diagnostics.
billion in 2015, almost 6 market of biomedical The market scale is
times the amount (RMB materials, accounting for predicted to be about
53.5 billion) in 2007 22% of global market. RMB 38.4 billion in 2018,
with a compound annual
growth rate of 17%
Bio-agriculture
biological breeding high-quality farm-oriented
biological products
The Chinese government listed Biological Over 1,000 enterprises in China
transgenic breeding technology in the
National High Technology Program, feeds are dedicated towards production
National Basic Research Programme and processing of feed additives
for R&D support
Till the end of 2015, China had
the bio-breeding industry has been Biological registered 3,435,417 different
listed as one of the Strategic Emerging Pesticide pesticides, 4,293 (with antibiotics)
Industries. biological pesticides involving 112
active ingredients
During the 12th "Five-Year Plan",
China had obtained 137 critical genes By the end of 2015, China had
with great breeding values, 1,036 Veterinary
registered 4,293 biological
patents, and a series of notable biological pesticides involving 112 active
achievements including insect
resistant cotton, insect resistant
products ingredients
maize, and herbicide-resistant soybean
Bio-based manufacturing
bio-based products
bio-based bio-based bulk fermentation green
materials chemicals products bioprocesses
From the 12th "Five-Year Plan", the Chinese biological fermentation industry
generally maintained a stable developmental trend.
amino acid: 3.7 million tons
The output of major bio-fermented
products:
organic acids: 2.1 million tons
Starch: 12 million tons
enzyme products: 1.2 million tons
2010 2015 fermented yeast: 0.32 million tons
functional fermented products: 3.4
18 million tons 24.3 million tons million tonsBioenergy
China is the third biggest country in the world producing and utilizing
bioethanol, second only to the USA and Brazil.
In 2014, COFCO and Sinopec group had developed
the whole set of production technology of cellulose
ethanol by using various raw materials with a yield
研 of 50,000 tons every year.
究
The bioethanol yield
in 2014 in China was Shandong Longlive Biotechnology invested to
about 2 million tons
construct a project to comprehensively utilize 0.4
million tons of straw, which would produce 30,000
tons of cellulose ethanol every year.
China's biodiesel Heilongjiang Jianye Fuel and Denmark Biofuel
industry is in the Technology cooperated to construct a large
growth phase comprehensive utilization and processing base for
the total capacity of straw, which would produce 300,000 tons of
biodiesel: 3-3.5 cellulose ethanol with straw every year.
million tonsBio-based environmental protection
Output Values of Till 2015, annual output value of
Environmental Protection biological environmental protection
Industry in China in 2000-2015 reached RMB 150 billion
Development of biological environmental
O U T P U T VA LU E ( R M B O O O B I L L I O N)
protection industry in China has the
following 3 characters:
Output value (RMB OOO billion)
4.55 1. Environmental protection
3.91
3.39
industry is continuously increasing
2.99 2. Biological environmental
protection technology and products
continuously improves
0.46
0.17 3. Environmental service industry
2000 2004 2012 2013 2014 2015 develops relatively quicklyBiotechnology service
In 2015, annual output value of biological service industry
reached RMB 150 billion.
CRO industry CRO market CMO industry
• started relatively late • the CRO market value • CMO industry in the
• WuXi AppTec, Shang in China was only development phase
Pharma, Tigermed, RMB 4.8 billion in • The market value will
and Boji 2007 and about RMB be over RMB 30
Pharmaceutical 38 billion in 2015 billion in 2017
marking the gradual • The average annual
rise of the industry growth rate 17.4%
from 2012 to 2017Strategies and approaches for advancing
bioindustry development
Introducing talent and
intelligence
Increasing policy Strengthening
support innovation capacity
Strengthening Increasing capital
international
collaboration
investmentThank you
You can also read
